• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

不吸烟的伴有血管痉挛性心绞痛患者的血浆谷氨酸升高与血浆胱氨酸和抗氧化能力有关。

Increased plasma glutamate in non-smokers with vasospastic angina pectoris is associated with plasma cystine and antioxidant capacity.

机构信息

Department of Cardiology, Kanazawa Medical University, Ishikawa, Japan.

Department of Forensic Medicine, Juntendo University School of Medicine, Tokyo, Japan.

出版信息

Scand Cardiovasc J. 2022 Dec;56(1):180-186. doi: 10.1080/14017431.2022.2085884.

DOI:10.1080/14017431.2022.2085884
PMID:35695518
Abstract

. Endothelial dysfunction caused by oxidative stress plays an important role in the development of vasospastic angina pectoris (VSAP). Glutamate causes endothelial dysfunction by generating oxidative stress, and it inhibits cystine import into endothelial cells via the cystine/glutamate antiporter (X), which leads to depletion of antioxidant glutathione. However, whether glutamate and cystine are implicated in the pathogenesis of VSAP remains unclear. We investigated plasma glutamate and cystine levels, oxidative stress markers and antioxidant capacity in non-smoker patients with VSAP to determine whether glutamate and cystine are associated with the development of VSAP. We assessed 49 non-smokers assigned to groups with ( = 27) and without ( = 22) VSAP, and also measured plasma glutamate, cystine, nitrotyrosine, reactive oxygen metabolites and biological antioxidant potential. . Plasma glutamate and cystine values were significantly higher in the group with, than without VSAP (59.8 ± 25.7 vs. 43.5 ± 18.7 µmol/L,  = .016 and 35.3 ± 14.2 vs. 25.2 ± 9.1 µmol/L,  = .0056, respectively). Plasma glutamate and cystine values were significantly and positively associated ( = 0.32,  = .027). Levels of the oxidative stress markers nitrotyrosine and reactive oxygen metabolites, and biological antioxidant potential of as a measure of antioxidant capacity, did not significantly differ between the two groups. However, glutamate and biological antioxidant potential values were significantly and negatively associated ( = -0.3,  = .036). . Plasma glutamate levels were increased in patients with VSAP who did not smoke, and they were positively associated with plasma cystine and negatively associated with the biological antioxidant potential levels.

摘要

氧化应激引起的内皮功能障碍在血管痉挛性心绞痛(VSAP)的发展中起着重要作用。谷氨酸通过产生氧化应激导致内皮功能障碍,通过胱氨酸/谷氨酸反向转运体(X)抑制胱氨酸进入内皮细胞,导致抗氧化谷胱甘肽耗竭。然而,谷氨酸和胱氨酸是否与 VSAP 的发病机制有关尚不清楚。我们研究了非吸烟者 VSAP 患者的血浆谷氨酸和胱氨酸水平、氧化应激标志物和抗氧化能力,以确定谷氨酸和胱氨酸是否与 VSAP 的发展有关。我们评估了 49 名非吸烟者,分为有( = 27)和没有( = 22)VSAP 的两组,并测量了血浆谷氨酸、胱氨酸、硝基酪氨酸、活性氧代谢物和生物抗氧化能力。血浆谷氨酸和胱氨酸值在有 VSAP 的组中明显高于无 VSAP 的组(59.8 ± 25.7 与 43.5 ± 18.7 μmol/L,  = .016 和 35.3 ± 14.2 与 25.2 ± 9.1 μmol/L,  = .0056,分别)。血浆谷氨酸和胱氨酸值呈显著正相关( = 0.32,  = .027)。两组之间的氧化应激标志物硝基酪氨酸和活性氧代谢物水平以及作为抗氧化能力的生物抗氧化能力没有显著差异。然而,谷氨酸和生物抗氧化能力值呈显著负相关( = -0.3,  = .036)。在不吸烟的 VSAP 患者中,血浆谷氨酸水平升高,与血浆胱氨酸呈正相关,与生物抗氧化能力呈负相关。

相似文献

1
Increased plasma glutamate in non-smokers with vasospastic angina pectoris is associated with plasma cystine and antioxidant capacity.不吸烟的伴有血管痉挛性心绞痛患者的血浆谷氨酸升高与血浆胱氨酸和抗氧化能力有关。
Scand Cardiovasc J. 2022 Dec;56(1):180-186. doi: 10.1080/14017431.2022.2085884.
2
Increased levels of the oxidative stress marker, nitrotyrosine in patients with provocation test-induced coronary vasospasm.激发试验诱导的冠状动脉痉挛患者中氧化应激标志物硝基酪氨酸水平升高。
J Cardiol. 2014 Aug;64(2):86-90. doi: 10.1016/j.jjcc.2013.11.017. Epub 2014 Jan 4.
3
Reactive oxygen species involved in the glutamate toxicity of C6 glioma cells via xc antiporter system.活性氧通过xc逆向转运体系统参与C6胶质瘤细胞的谷氨酸毒性作用。
Neuroscience. 1996 Jul;73(1):201-8. doi: 10.1016/0306-4522(96)00025-5.
4
Mechanisms of oxidative glutamate toxicity: the glutamate/cystine antiporter system xc- as a neuroprotective drug target.氧化谷氨酸毒性的机制:谷氨酸/胱氨酸反向转运蛋白系统 xc-作为神经保护药物靶点。
CNS Neurol Disord Drug Targets. 2010 Jul;9(3):373-82. doi: 10.2174/187152710791292567.
5
[Bronchial hyperresponsiveness in patients with vasospastic angina pectoris (VSAP)].[变异性心绞痛(VSAP)患者的支气管高反应性]
Nihon Kyobu Shikkan Gakkai Zasshi. 1997 Oct;35(10):1035-9.
6
Dysregulated Glutamate Transporter SLC1A1 Propels Cystine Uptake via Xc for Glutathione Synthesis in Lung Cancer.谷氨酸转运蛋白 SLC1A1 失调通过 Xc 推动胱氨酸摄取用于肺癌谷胱甘肽合成。
Cancer Res. 2021 Feb 1;81(3):552-566. doi: 10.1158/0008-5472.CAN-20-0617. Epub 2020 Nov 23.
7
Identification, Expression, and Roles of the Cystine/Glutamate Antiporter in Ocular Tissues.半胱氨酸/谷氨酸反向转运体在眼部组织中的鉴定、表达和作用。
Oxid Med Cell Longev. 2020 Jun 18;2020:4594606. doi: 10.1155/2020/4594606. eCollection 2020.
8
Cooperative action of glutamate transporters and cystine/glutamate antiporter system Xc- protects from oxidative glutamate toxicity.谷氨酸转运体与胱氨酸/谷氨酸反向转运体系统Xc-的协同作用可保护细胞免受氧化性谷氨酸毒性的影响。
J Neurochem. 2006 Aug;98(3):916-25. doi: 10.1111/j.1471-4159.2006.03921.x. Epub 2006 Jun 12.
9
A mechanism for glutamate toxicity in the C6 glioma cells involving inhibition of cystine uptake leading to glutathione depletion.一种C6胶质瘤细胞中谷氨酸毒性的机制,涉及抑制胱氨酸摄取导致谷胱甘肽耗竭。
Neuroscience. 1992 Jun;48(4):903-14. doi: 10.1016/0306-4522(92)90278-a.
10
High-Throughput Assay Development for Cystine-Glutamate Antiporter (xc-) Highlights Faster Cystine Uptake than Glutamate Release in Glioma Cells.用于胱氨酸-谷氨酸反向转运体(xc-)的高通量检测方法开发突显了胶质瘤细胞中胱氨酸摄取比谷氨酸释放更快的特点。
PLoS One. 2015 Aug 7;10(8):e0127785. doi: 10.1371/journal.pone.0127785. eCollection 2015.

引用本文的文献

1
The correlation between cumulative cigarette consumption and infarction-related coronary spasm in patients with ST-segment elevation acute myocardial infarction across different age groups.不同年龄组ST段抬高型急性心肌梗死患者累积吸烟量与梗死相关冠状动脉痉挛之间的相关性。
Sci Rep. 2025 Jan 2;15(1):253. doi: 10.1038/s41598-024-84125-5.
2
Interplay of serum taurine, S-adenosylmethionine, and cysteine levels in cancer risk: a prospective study.血清牛磺酸、S-腺苷甲硫氨酸和半胱氨酸水平在癌症风险中的相互作用:一项前瞻性研究。
Front Pharmacol. 2024 Dec 18;15:1507125. doi: 10.3389/fphar.2024.1507125. eCollection 2024.
3
Prognostic Value of Redox Status Biomarkers in Patients Presenting with STEMI or Non-STEMI: A Prospective Case-Control Clinical Study.
氧化还原状态生物标志物在ST段抬高型心肌梗死或非ST段抬高型心肌梗死患者中的预后价值:一项前瞻性病例对照临床研究
J Pers Med. 2023 Jun 26;13(7):1050. doi: 10.3390/jpm13071050.